Top Markets
Coin of the day
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Classement en actions #37014
Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating... Acticor Biotech SAS is a clinical-stage biotechnology firm focused on creating therapies for the acute phase of thrombotic conditions. The company's lead compound, glenzocimab, is a humanized monoclonal antibody fragment specifically designed to target a particular platelet glycoprotein. Currently, Acticor Biotech is advancing two clinical programs, both in Phase II/III, for the registration of treatments for ischemic stroke. Additionally, it is conducting two other Phase II trials concerning significant cardiovascular emergencies, with anticipated clinical data expected from both its ischemic stroke research and studies related to COVID-19 respiratory distress syndrome. Established in 2013, the company operates from its headquarters in Paris, France.
Prix de l'action
$0.25974701
Dernière synchronisation: 2025-01-06
Capitalisation boursière
$2.04M
Changement (1 jour)
0.74%
Changement (1 an)
0.00%
Pays
FR
Échange Acticor Biotech SAS (ALACT)

Catégorie

Historique du prix de l'action pour Acticor Biotech SAS (ALACT)
Prix de clôture le plus élevé : $0.26 le 2025-01-01

Prix de clôture le plus bas : $7.56 le 2021-11-01
Historique du prix de l'action de Acticor Biotech SAS de 2021 à 2026
Performance annuelle du prix de l'action
Année Performance
2025 -4.45%
2024 -91.43%
2023 -58.60%
2022 31.92%
2021 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$514.65 30.88%
US
$990.22 30.84%
NL
$122.35 -10.30%
AU
$143.28 499.99%
US
$697.62 1.32%
CH